DK0385630T3 - 1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler - Google Patents

1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler

Info

Publication number
DK0385630T3
DK0385630T3 DK90301766.3T DK90301766T DK0385630T3 DK 0385630 T3 DK0385630 T3 DK 0385630T3 DK 90301766 T DK90301766 T DK 90301766T DK 0385630 T3 DK0385630 T3 DK 0385630T3
Authority
DK
Denmark
Prior art keywords
antivirals
imidazo
quinoline
amines
Prior art date
Application number
DK90301766.3T
Other languages
English (en)
Inventor
John F Gerster
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Application granted granted Critical
Publication of DK0385630T3 publication Critical patent/DK0385630T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
DK90301766.3T 1989-02-27 1990-02-19 1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler DK0385630T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31603589A 1989-02-27 1989-02-27

Publications (1)

Publication Number Publication Date
DK0385630T3 true DK0385630T3 (da) 1997-05-12

Family

ID=23227183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90301766.3T DK0385630T3 (da) 1989-02-27 1990-02-19 1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler

Country Status (9)

Country Link
EP (1) EP0385630B1 (da)
JP (1) JP2941336B2 (da)
KR (1) KR0179992B1 (da)
AU (1) AU630921B2 (da)
CA (2) CA2355852A1 (da)
DE (1) DE69029212T2 (da)
DK (1) DK0385630T3 (da)
ES (1) ES2094141T3 (da)
NZ (1) NZ232602A (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US4988815A (en) * 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
US5179107A (en) * 1990-09-07 1993-01-12 Schering Corporation Antiviral quinolinone compounds
JPH07110853B2 (ja) * 1990-09-07 1995-11-29 シェリング・コーポレーション 抗ウイルス化合物および抗高血圧化合物
EP0872478B1 (en) * 1991-03-01 2002-12-18 Minnesota Mining And Manufacturing Company Intermediates for the preparation of 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
US5268376A (en) * 1991-09-04 1993-12-07 Minnesota Mining And Manufacturing Company 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5266575A (en) * 1991-11-06 1993-11-30 Minnesota Mining And Manufacturing Company 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US5395937A (en) * 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5622965A (en) * 1993-03-12 1997-04-22 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists
US5648516A (en) * 1994-07-20 1997-07-15 Minnesota Mining And Manufacturing Company Fused cycloalkylimidazopyridines
US5352784A (en) * 1993-07-15 1994-10-04 Minnesota Mining And Manufacturing Company Fused cycloalkylimidazopyridines
KR100341341B1 (ko) * 1993-07-15 2002-11-25 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 이미다조[4,5-c]피리딘-4-아민
US5644063A (en) * 1994-09-08 1997-07-01 Minnesota Mining And Manufacturing Company Imidazo[4,5-c]pyridin-4-amine intermediates
US5482936A (en) * 1995-01-12 1996-01-09 Minnesota Mining And Manufacturing Company Imidazo[4,5-C]quinoline amines
US5741908A (en) 1996-06-21 1998-04-21 Minnesota Mining And Manufacturing Company Process for reparing imidazoquinolinamines
US5840500A (en) * 1996-07-11 1998-11-24 Trega Biosciences, Inc. Quinoline derivatives and quinoline combinatorial libraries
HUP9904665A3 (en) 1996-10-25 2000-11-28 Minnesota Mining And Mfg Co Sa Immune response modifier compounds for treatment of th2 mediated and related diseases
US5939090A (en) 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
UA74852C2 (en) 2000-12-08 2006-02-15 3M Innovative Properties Co Urea-substituted imidazoquinoline ethers
GB0211649D0 (en) * 2002-05-21 2002-07-03 Novartis Ag Organic compounds
DK1543002T3 (da) 2002-07-23 2006-12-27 Teva Gyogyszergyar Zartkoeruee Fremstilling af 1H-imidazo (4,5-c) quinolin-4-aminer via 1H-imidazo (4,5-c) quinolin-4-phtalimid mellemprodukter
PL374866A1 (en) 2002-07-26 2005-11-14 Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag Preparation of 1h-imidazo [4,5-c] quinolin-4-amines via novel 1h-imidazo [4,5-c] quinolin-4-cyano and 1h-imidazo [4,5-c] quinolin-4-carboxamide intermediates
MXPA06001669A (es) 2003-08-12 2006-04-28 3M Innovative Properties Co Compuestos que contienen imidazo-oxima sustituidos.
NZ545412A (en) 2003-08-27 2008-12-24 Coley Pharm Group Inc Aryloxy and arylalkyleneoxy substituted imidazoquinolines
JP2007504269A (ja) 2003-09-05 2007-03-01 スリーエム イノベイティブ プロパティズ カンパニー Cd5+b細胞リンパ腫の治療方法
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
EP1673087B1 (en) 2003-10-03 2015-05-13 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
CN1906192A (zh) 2003-11-14 2007-01-31 3M创新有限公司 羟胺取代的咪唑环化合物
WO2005048933A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AU2004293078B2 (en) * 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
EP1699788A2 (en) 2003-12-30 2006-09-13 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides
US8697873B2 (en) 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合[1,2]イミダゾ[4,5−c]環状化合物
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ,インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
EP1846405A2 (en) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
CA2597446A1 (en) * 2005-02-11 2006-08-31 Coley Pharmaceutical Group, Inc. Substituted imidazoquinolines and imidazonaphthyridines
CA2602683A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
BRPI0713711A2 (pt) 2006-06-20 2012-10-30 Transgene Sa vacina viral recombinante, kit para vacinação, e, método para usar pelo menos um composto
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
US9227969B2 (en) 2013-08-14 2016-01-05 Novartis Ag Compounds and compositions as inhibitors of MEK
BR112018071347A2 (pt) * 2016-04-19 2019-02-05 Innate Tumor Immunity Inc moduladores de nlrp3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1271477A (en) * 1983-11-18 1990-07-10 John F. Gerster 1h-imidazo[4,5-c]quinolin-4-amines
IL73534A (en) 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
CA1306260C (en) * 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines

Also Published As

Publication number Publication date
CA2355852A1 (en) 1990-08-27
NZ232602A (en) 1992-10-28
DE69029212T2 (de) 1997-05-22
ES2094141T3 (es) 1997-01-16
AU5005490A (en) 1990-08-30
JP2941336B2 (ja) 1999-08-25
EP0385630B1 (en) 1996-11-27
KR910015575A (ko) 1991-09-30
EP0385630A3 (en) 1992-01-02
JPH0327380A (ja) 1991-02-05
DE69029212D1 (de) 1997-01-09
KR0179992B1 (ko) 1999-03-20
CA2010430A1 (en) 1990-08-27
AU630921B2 (en) 1992-11-12
EP0385630A2 (en) 1990-09-05

Similar Documents

Publication Publication Date Title
AU632099B2 (en) Olefinic 1h-imidazo (4,5-c)quinolin-4-amines
DE69003575D1 (de) Formulierung, ein imidazo(4,5-c)quinolin-derivat enthaltend.
AU5005490A (en) 1h-imidazo(4,5-c)quinolin-4-amines
DK0516349T3 (da) 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
FI921279L (fi) Amino-b-lyasenzyminhibitorer som deodoranter.
FI900762A0 (fi) Tris-hydroximetylalkanestrar som fettimitationer med laog kalorihalt.
NO900741D0 (no) Tris-hydroxymethyl-lavere-alkanestere som fettimitasjoner.
FI893605A0 (fi) Imidatso (4,5-b) pyridinderivat.
FI892214A0 (fi) Kopparlegering foer anvaendning som motstaondssvetselektrod.
FI895483L (fi) Som slaglod anvaendbara kopparblandningar.
FI906270L (fi) Imidazo/4,5-c/pyridiner som antiosteoporotiska aemnen.
EP0417760A3 (en) Phenylalkanoyl substituted imidazo(4,5-c) pyridines
FI900038A7 (fi) Nya substituerade pyrido(2,3-d)pyrimidiner.
FI901277A7 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenyleeni PG1z-johdannaisia
FI904017A0 (fi) Pyrido/3,4-b/1,4/bensoxazepiner, foerfarande foer framstaellning av dessa och anvaendning av dessa som laekemedel.
FI900940A0 (fi) Tryckt kretsskiva som foerhindrar elektromagnetisk interferens.
FI871980A0 (fi) Pyrazolo/3,4-b/pyridinderivat, foerfaranden och mellanprodukter foer deras framstaellning och deras anvaendning som herbicider.
FI905238A0 (fi) Foerbraenningsmotor foer fartyg som transporterar foerbraenningsgas.
FI881165A7 (fi) 5-hetero- eller aryl-substituerade imidazo /2,1-a/ isokinoliner.
FI922124L (fi) Azabicykloamider och -estrar som 5-ht3-receptorantagonister.
KR880001629A (ko) 1,3,5-트리티안 유도체
FI905274A0 (fi) Katod som frigoer vaete.
MA21517A1 (fr) Tetrahydroimidazo (1,4) benzodiazepin-2-ones antivirales .
FI910281A0 (fi) Kopplingsarrangemang som bildar triangelpuls.
LT2332B (lt) Nitronaftalino monopakeisti sulfamidai kaip pusiauproduktai nesimetriniu 5-aminonaftalin-1-sulfamidudariniu gavimui